M 14 (Methotrexate 2.5 mg)

Pill imprint M 14 has been identified as Methotrexate sodium 2.5 mg.

Methotrexate is used in the treatment of rheumatoid arthritis; psoriasis; psoriatic arthritis; acute lymphoblastic leukemia; small cell lung cancer (and more), and belongs to the drug classes antimetabolites, antipsoriatics, antirheumatics, other immunosuppressants. Not for use in pregnancy. Methotrexate 2.5 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for M 14

Methotrexate sodium 2.5 mg M 14
Methotrexate sodium 2.5 mg M 14  Front
Methotrexate sodium 2.5 mg M 14  Back
Methotrexate sodium 2.5 mg M 14
Methotrexate sodium
Imprint:
M 14
Strength:
2.5 mg
Color:
Orange
Size:
6.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Antimetabolites
Antipsoriatics
Antirheumatics
Other immunosuppressants
Pregnancy Category:
X - Not for use in pregnancy
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-0014
Inactive Ingredients:
silicon dioxide
lactose monohydrate
magnesium stearate
microcrystalline cellulose
corn starch
sodium carbonate monohydrate
sodium lauryl sulfate
sodium starch glycolate type A potato
FD&C Red No. 40
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0670 UDL Laboratories Inc
21695-0111 Rebel Distributors Corp (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)